Aemetis, Inc financial data

Symbol
AMTX on Nasdaq
Industry
Industrial Organic Chemicals
Location
20400 Stevens Creek Blvd, Suite 700, Cupertino, CA
State of incorporation
Nevada
Fiscal year end
December 31
Former names
AE Biofuels, Inc. (to 11/16/2011), AE BIOFUELS, INC. (to 11/16/2011), MARWICH II LTD (to 12/11/2007)
Latest financial report
10-Q - Q2 2024 - Aug 5, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 39.2 % +125%
Quick Ratio 12 % +66.1%
Return On Equity 66.5 %
Return On Assets -68 % -200%
Operating Margin -9.82 % +23.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 47.2M shares +21.5%
Entity Public Float 253M USD +73.9%
Common Stock, Value, Issued 46K USD +21.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 232M USD +32%
Research and Development Expense 152K USD -15.6%
Operating Income (Loss) -40.6M USD -12%
Nonoperating Income (Expense) 41K USD +32.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -101M USD +27.1%
Income Tax Expense (Benefit) 385K USD -63.9%
Net Income (Loss) Attributable to Parent -29.2M USD -15.4%
Earnings Per Share, Basic 0.27 USD/shares
Earnings Per Share, Diluted 0.27 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 234K USD -93.3%
Accounts Receivable, after Allowance for Credit Loss, Current 1.26M USD -19.7%
Inventory, Net 10.2M USD +37.3%
Other Assets, Current 2.35M USD -9.06%
Assets, Current 23.9M USD +14.1%
Property, Plant and Equipment, Net 194M USD +6.16%
Operating Lease, Right-of-Use Asset 2.2M USD -2.79%
Assets 232M USD +9.17%
Accounts Payable, Current 28.8M USD -5.07%
Liabilities, Current 121M USD +11%
Operating Lease, Liability, Noncurrent 1.81M USD -9.12%
Other Liabilities, Noncurrent 5.24M USD -12.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -5.71M USD -7.3%
Retained Earnings (Accumulated Deficit) -529M USD -10%
Stockholders' Equity Attributable to Parent -249M USD -4.19%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -249M USD -4.19%
Liabilities and Equity 232M USD +9.17%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -10.3M USD +8.71%
Net Cash Provided by (Used in) Financing Activities 10.6M USD -6.93%
Net Cash Provided by (Used in) Investing Activities -1.68M USD -95.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.34M USD -72.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.74M USD -31.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.96M USD +95.6%
Deferred Tax Assets, Valuation Allowance 135M USD +42.2%
Deferred Tax Assets, Gross 144M USD +36.4%
Operating Lease, Liability 2.29M USD -3.34%
Depreciation 7.32M USD +15.5%
Payments to Acquire Property, Plant, and Equipment 5.4M USD +146%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -48.5M USD +65.7%
Lessee, Operating Lease, Liability, to be Paid 4.17M USD +28.4%
Property, Plant and Equipment, Gross 255M USD +7.66%
Operating Lease, Liability, Current 475K USD +27.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 681K USD -0.15%
Lessee, Operating Lease, Liability, to be Paid, Year One 682K USD +2.25%
Operating Lease, Weighted Average Discount Rate, Percent 0.14 pure 0%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.88M USD +114%
Lessee, Operating Lease, Liability, to be Paid, Year Three 626K USD -8.08%
Deferred Tax Assets, Operating Loss Carryforwards 67.6M USD -0.85%
Preferred Stock, Shares Issued 0 shares -100%
Lessee, Operating Lease, Liability, to be Paid, Year Four 645K USD +3.04%
Operating Lease, Payments 753K USD -0.66%
Amortization of Intangible Assets 12K USD 0%
Depreciation, Depletion and Amortization 5.3M USD +7.69%
Deferred Tax Assets, Net of Valuation Allowance 8.76M USD -16.3%
Interest Expense 43.1M USD +24.8%